Skip to main content

Table 1 Inclusion and exclusion criteria

From: Mycophenolate sodium treatment in patients with primary Sjögren syndrome: a pilot trial

Inclusion criteria Diagnosis of primary Sjögren syndrome based on the American-European Consensus criteria [13]
  Erythrocyte sedimentation rate of greater than 25 mm/hour and hypergammaglobulinemia (>1,500 mg/dL)
  Presence of anti-SSA and/or SSB antibodies and/or rheumatoid factor
  Requirement of artificial teardrops due to symptomatic sicca syndrome
  Inadequate response or intolerance of prior treatment with hydroxychloroquine and/or azathioprine
  Adequate contraception for females of childbearing potential
Exclusion criteria Age below 18 or above 75 years
  Secondary Sjögren syndrome
  History of cancer, severe infections, or other uncontrolled diseases
  Treatment with concomitant disease-modifying antirheumatic drugs within the last 8 weeks before baseline evaluation
  Prednisolone dose of greater than 5 mg/day or changes of prednisolone dose within the last 4 weeks before baseline
  Use of secretagogues (for example, pilocarpine and civemeline) or medications that potentially diminish exocrine gland function (for example, tricyclic antidepressants and anticholinergic drugs)
  Pregnant or lactating women